The parent company of hair-loss prevention product Keeps is launching another telemedicine service called Cove, this time focusing on treating those with migraines

Thirty Madison, the company behind Keeps—a digital service that provides hair loss solutions for men—is aiming to disrupt the healthcare sector through telemedicine. The company is debuting Cove, a service for those suffering from migraines.

With $22.7 million of funding under their belts, the Thirty Madison team plans to keep on expanding its growing Keeps brand, a platform that gives access to affordable, backed-by-science, FDA-approved treatments for hair loss, as well as insert Cove into the market. “This need doesn’t stop with hair loss though—it can scale to many other chronic conditions where populations are underserved. With more than 39 million people in the United States suffering from migraines, we’re launching Cove to offer personalized treatment solutions for migraine sufferers,” Steven Gutentag, co-founder of Thirty Madison told PSFK.

Cove will use a similar model to Keeps, offering users a slew of doctors located in their state who can chat with them online and prescribe their needed meds based on their individual ailments. Using the online platform, the company is able to offer personalized care and support, in a much faster, convenient and affordable way than the traditional healthcare model. “The telemedicine healthcare model truly caters to the needs of the modern consumer, meeting them where, when and how they want to be met. Everything from your consultation and diagnosis to ongoing access to your doctors for questions about your care is quite literally at your fingertips,” said Gutentag.

But, just because it’s faster doesn’t mean patients have to give up any personal touch they could get from a visit to the doctor’s office. Thirty Madison has adopted a model to ensure everyone receives attentive care. “Like Keeps, Cove customers go through a rigorous online diagnostic consultation, built-in partnership with leading experts in the field, to develop the right plan,” said Gutentag. “Physicians look at medical history, including the length of time they’ve experienced migraines and any past medications they’ve taken to treat them, as well as other factors, in order to build the right treatment plans.” Plus, it’s definitely cheaper—by eliminating the middle man and working closely with drug manufacturers, Thirty Madison is able to deliver your meds, straight to customers’ doors, for a lower price than visiting a traditional doctor and picking it up at a local pharmacy.

Gutentag envisions a future where telemedicine is used not only for conditions such as migraines and hair loss, but also as a way to connect doctors to patients and specialized care. “Telemedicine is still in its infancy, and you’re seeing it continue to evolve as technology improves and patients become more comfortable with this method of interacting with physicians. We believe telemedicine will play a strong role in helping expand access to high quality, specialized care,” he said. “Our focus is in chronic conditions, but telemedicine can be very beneficial for non-chronic conditions, such as remotely connecting specialists to patients in hospitals and medical centers without traditional access to those experts.”

Cove | Keeps

Thirty Madison, the company behind Keeps—a digital service that provides hair loss solutions for men—is aiming to disrupt the healthcare sector through telemedicine. The company is debuting Cove, a service for those suffering from migraines.

With $22.7 million of funding under their belts, the Thirty Madison team plans to keep on expanding its growing Keeps brand, a platform that gives access to affordable, backed-by-science, FDA-approved treatments for hair loss, as well as insert Cove into the market. “This need doesn’t stop with hair loss though—it can scale to many other chronic conditions where populations are underserved. With more than 39 million people in the United States suffering from migraines, we’re launching Cove to offer personalized treatment solutions for migraine sufferers,” Steven Gutentag, co-founder of Thirty Madison told PSFK.